Related Experiment Video

Updated: Aug 15, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors

Zusen Fan1, Ping Yu, Yang Wang

  • 1National Laboratory of Biomacromolecules and Center for Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, 15 Datun Rd, Chaoyang District, Beijing 100101, China. fanz@moon.ibp.ac.cn

Blood
|October 15, 2005
PubMed

Insights

Natural killer (NK) cells, activated by LIGHT, are crucial for adaptive immunity against tumors. They facilitate CD8+ T cell priming via IFN-gamma, essential for tumor rejection.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cellular Immunology

Background:

  • Natural killer (NK) cells are recognized for innate immunity against viral infections and tumors.
  • The precise mechanisms by which NK cells contribute to adaptive anti-tumor immunity remain incompletely understood.

Purpose of the Study:

  • To investigate the role of LIGHT (TNFSF14) in NK cell activation and its impact on anti-tumor adaptive immunity.
  • To elucidate the crosstalk between NK cells and CD8+ T cells within the tumor microenvironment.

Main Methods:

  • Utilized LIGHT as a ligand engaging Herpesvirus entry mediator (HVEM) on NK cells to study NK cell activation.
  • Assessed tumor rejection in mouse models with varying NK and CD8+ cell populations.
  • Investigated the role of IFN-gamma in NK cell-mediated CD8+ T cell priming and tumor rejection.

Main Results:

  • LIGHT engagement with HVEM on NK cells leads to NK cell activation and expansion.
  • Tumor rejection is dependent on both NK and CD8+ cells, with LIGHT expression promoting rejection.
  • Activated NK cells prime tumor-specific CD8+ T cells in an IFN-gamma-dependent manner, without directly killing tumor cells.
  • Intratumoral depletion of NK cells or IFN-gamma impairs CD8+ T cell-mediated tumor rejection.

Conclusions:

  • LIGHT is a critical activator of NK cells, promoting their expansion and function in anti-tumor responses.
  • Activated NK cells play a vital helper role in priming CD8+ T cells and overcoming T cell tolerance at the tumor site.
  • IFN-gamma is essential for NK cell-mediated activation of cytotoxic T lymphocytes (CTLs), highlighting a key mechanism in adaptive anti-tumor immunity.

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...